Skye Bioscience, Inc. Interest Expense on Debt
Skye Bioscience, Inc. (SKYE) reported Interest Expense on Debt of $2.10 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2023-08-07
- Skye Bioscience, Inc. interest expense, debt for the quarter ending 2023-06-30 was $2.10K.
- Skye Bioscience, Inc. interest expense, debt for the quarter ending 2023-03-31 was $1.01K.
- Skye Bioscience, Inc. interest expense, debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. interest expense, debt for the quarter ending 2022-09-30 was $0.00.
- Skye Bioscience, Inc. interest expense, debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Skye Bioscience, Inc. interest expense, debt for fiscal 2021 was $446.00, a 44.67% decline from fiscal 2020.
- Skye Bioscience, Inc. interest expense, debt for fiscal 2020 was $806.00.
- Skye Bioscience, Inc. interest expense, debt for fiscal 2019 was $0.00.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2023-06-30 | $2.10K 10-Q · filed 2023-08-07 | $3.10K 10-Q · filed 2023-08-07 | $3.10K derived: sum of 3 quarters · filed 2023-08-07 | $3.10K derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | $1.01K 10-Q · filed 2023-05-12 | $1.01K derived: sum of 2 quarters · filed 2023-05-12 | $1.01K derived: sum of 3 quarters · filed 2023-05-12 | $1.01K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-08-07 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-08-07 | $0.00 10-Q · filed 2022-11-14 | $1.00 derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $1.00 derived: sum of 3 quarters · filed 2023-08-07 | $1.00 derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $1.00 derived: sum of 2 quarters · filed 2023-05-12 | $1.00 derived: sum of 3 quarters · filed 2023-05-12 | $160.00 derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.00 derived: sum of 2 quarters · filed 2023-03-31 | $160.00 derived: sum of 3 quarters · filed 2023-03-31 | $446.00 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $159.00 derived: sum of 2 quarters · filed 2022-11-14 | $445.00 10-Q · filed 2022-11-14 | $740.00 derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $159.00 10-Q · filed 2021-08-06 | $445.00 10-Q · filed 2021-08-06 | $740.00 derived: sum of 3 quarters · filed 2022-05-06 | $1.03K derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-03-31 | $286.00 10-Q · filed 2022-05-06 | $581.00 derived: sum of 2 quarters · filed 2022-05-06 | $875.00 derived: sum of 3 quarters · filed 2022-05-06 | $1.09K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $295.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $589.00 derived: sum of 2 quarters · filed 2022-03-28 | $807.00 derived: sum of 3 quarters · filed 2022-03-28 | $806.00 10-K · filed 2022-03-28 |
| 2020-09-30 | $294.00 10-Q · filed 2021-11-10 | $512.00 derived: sum of 2 quarters · filed 2021-11-10 | $511.00 10-Q · filed 2021-11-10 | $512.00 derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $218.00 10-Q · filed 2021-08-06 | $218.00 10-Q · filed 2021-08-06 | $218.00 derived: sum of 3 quarters · filed 2021-08-06 | $218.00 derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-05-07 | $0.00 derived: sum of 3 quarters · filed 2021-05-07 | $0.00 derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $0.00 derived: sum of 2 quarters · filed 2021-03-02 | $0.00 derived: sum of 3 quarters · filed 2021-03-02 | $0.00 10-K · filed 2021-03-02 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |